Renal Function after Port Access and Median Sternotomy Mitral Valve Surgery
Background. Acute renal injury is an important postoperative complication of mitral valve surgery. We tested the hypothesis that minimally invasive port access (PA) surgery is linked to a smaller postoperative renal injury compared to the standard median Sternotomy (MS) technique.
Methods. Ninety-six patients in the PA group and 102 patients in the MS group were compared regarding postoperative renal dysfunction. Preoperative and maximal postoperative serum creatinine levels were used to calculate creatinine clearance which was implemented for the renal function assessment. Additionally, the new RIFLE classification for acute renal injury was used for the comparison of the postoperative kidney function. This classification is divided into 3 levels and in addition to the glomerular filtration rate, it is also based on urine output.
Results. The analysis of preoperative renal function did not demonstrate any significant differences between the two groups in any of the creatinine-based renal function markers. However, the comparison of the minimal postoperative creatinine clearance showed significantly lower values in the median sternotomy group. The conventional MS approach was confirmed as an independent renal risk factor in the multivariate analysis. The postoperative RIFLE classification comparison also showed higher postoperative renal impairment in the MS group.
Conclusion. With the limitations of a retrospective study, our results suggest that for mitral valve surgery the minimally invasive PA approach might be associated with lower postoperative renal injury compared to the conventional surgical technique.
Baines AD. 1994. Strategies and criteria for developing new urinalysis tests. Kidney Int 47(suppl): 137-41.nBellomo R, Ronco C, Kellum JA, et al. 2004. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second international Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 8:R204-12.nBove T, Calabro MG, Landoni G, et al. 2004. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth 18:442-5.nChertow GM, Lazarus JM, Christiansen CL, et al. 1997. Preoperative renal risk stratification. Circulation 95:878-84.nCockroft DW, Gault MH. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41.nDuncan L, Heathcote J, Djurdev O, Levin A. 2001. Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant 16:1042-6.nGersak B, Sostaric M, Kalisnik JM, Blumauer R. 2004. The preferable use of port access surgical technique for right and left atrial procedures. Heart Surg Forum 8:E354-63.nGlower DD, Landolfo KP, Clements F, et al. 1998. Mitral valve operation via port access versus median sternotomy. Eur J Cardiothorac Surg 16:S143-7.nHoste EA, Kellum JA. 2006. RIFLE criteria provide robust assessment of kidney dysfunction and correlate with hospital mortality. Crit Care Med 34:2016-7.nKouchoukos NT, Blackstone EH, Doty DB, et al. 2003. Hypothermia, circulatory arrest and cardiopulmonary bypass. In: Kirklin JW/ Barrat-Boyes Cardiac Surgery. 3rd ed. Philadelphia, PA: Churchill Livingstone: 105.nKuitunen A, Vento A, Suojaranta-Ylinen R, Pettil%o V. 2006. Acute renal failure after cardiac surgery: evaluation of the RIFLE Classification. Ann Thorac Surg 81:542-6.nLassnig A, Schmidlin D, Mouhieddine M, et al. 2004. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort Study. J Am Soc Nephrol 15:1597-605.nLin CI, Pan KY, Hsu PY, Yang HY, Guo HL, Huang CC. 2004. Preoperative 24-hour urine output as an independent predictor renal outcome in poor cardiac function patients after coronary artery bypass grafting. J Crit Care 19:92-8.nMcCreath BJ, Swaminathan M, Booth JV, et al. 2003. Mitral valve surgery and acute renal injury: port access versus median sternotomy. Ann Thorac Surg 75:812-9.nMora Mangano C, Boisvert D, Zhou S, Herskowitz A, Mangano DT. 2000. Small reductions in renal function following CABG independently predict prolonged hospitalization. Anesth Analg 90 (suppl):SCA35.nMora Mangano C, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano TD. 1998. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 128:194-203.nMyles PS, Scheinkestel C. 1993. Renal failure after cardiac surgery: Pathophysiology, prevention and treatment. Austral As J Cardiac Thorac Surg 2:140-4.nNational Kidney Foundation. 2002. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39:2(suppl 1):S76-S92.nRoques F, Nashef SAM, Michel P, et al. 1999. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816-23.nSostarsic M. 2005. Incisional administration of local anesthetic provides satisfactory analgesia following port access heart surgery. Heart Surg Forum 8:E406-8.nStafford Smith M. 2003. Perioperative renal dysfunction: Implications and strategies for protection. In: Newman MF, ed. Perioperative Organ Protection. Richmond, VA: Society of Cardiovascular Anesthesiologists 89-124.nStafford Smith M, Reddan DN, Phillips-Bute B, Newman MF, Winn MP. 2001. Association of perioperative creatinine-derived variables with mortality and other outcomes after coronary bypass surgery. Anesth Analg 92:SCA28.nSwedko JP, Clark HD, Paramsothy K, Akbari A. 2003. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 163:356-60.nTrof RJ, Di Maggio F, Leemreis J, Groeneveld AB. 2006. Biomarkers of acute renal injury and renal failure. Shock 26:245-53.nVerrier ED, Boyle EM Jr. 2004. Cardiopulmonary bypass: pathophysiology. In: Gardner TJ, Spray TL, eds. Operative Cardiac Surgery. 5th ed. London, Arnold: 58.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).